RESEARCH TRIANGLE PARK, N.C (PRWEB) February 06, 2013 -- Environmental Science, a division of Bayer CropScience LP, has launched Bayer Specticle® G – a versatile, pre-emergent herbicide that provides green industry professionals up to six months of broad-spectrum weed control for use in landscapes, including mulched areas and around ornamentals, and in warm-season turf. The company will feature Bayer Specticle G at the upcoming 2013 Golf Industry Show (GIS) in San Diego.
“Green industry professionals invest a lot of time and resources in the control of troublesome weeds,” said Jeff Michel, herbicide business manager at Bayer. “Specticle G sets a new standard for residual control at the lowest use rates on the market. This helps lawn and landscape maintenance managers save on time, fuel and labor costs by reducing the number of treatments needed to achieve optimal results.”
Bayer Specticle G protects against a broad spectrum of more than 80 grassy and broadleaf weeds, as well as annual sedges. The product requires up to 40 times less active ingredient than current standards, resulting in significantly less herbicide placed in the environment. In addition, unlike other pre-emergent herbicides, the applicator-friendly formulation will not stain or leave any odor behind after treatment.
“Specticle controls even the most stubborn weeds, like Poa annua,” said Michel. “It helps maintain premium, weed-free landscape beds for the entire growing season – making it one of the most effective tools in any turf manager’s arsenal.”
Application and Use
Bayer Specticle G is formulated for convenient storage, measuring and spreading. Apply the product at 100-200 lbs. of product per acre (2.3-4.6 lbs. per 1000 sq. ft.) around ornamentals. A subsequent application of Bayer Specticle G can be made within 90 days after the initial application to extend weed control provided that the total amount of product applied does not exceed 400 lbs. per acre (9.2 lbs. per 1000 sq. ft.) in a 12-month period.
For more information on Bayer Specticle G, please visit the Bayer booth at GIS 2013, #3438, or visit http://www.BackedbyBayer.com. Always read and follow label instructions.
Bayer, the Bayer Cross, and Specticle are registered trademarks of BAYER.
Bayer CropScience is committed to bringing new technology and solutions for agriculture and non-agricultural uses. For questions concerning the availability and use of products, contact a local Bayer CropScience representative, or visit Bayer CropScience online at bayercropscience.us.
About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 7.255 billion (2011) and is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 21,000 and is represented in more than 120 countries. This and further news is available at: press.bayercropscience.com.
Bayer CropScience Media Hotline, 1-877-879-6162
Find more information at bayercropscience.us.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Read the full story at http://www.prweb.com/releases/2013/2/prweb10400573.htm